Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-25-Speech-2-075-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-10-25"^^xsd:date2
dcterms:Is Part Of	lp_eu:Question Time (Commission)2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20111025.7.2-075-000"2
lpv:hasSubsequent	lp_eu:2011-10-25-Speech-2-076-0002
lpv:speaker	lp:Baroness Sarah Ludford2
lpv:spoken text	"One of the 12 priorities is the issue of intellectual property rights, including patents, and emphasis has been placed on how essential patents are for innovation, jobs and, of course, research. What is the Commission’s reaction to the recent ruling of the European Court of Justice that patents for the use of stem cells are not possible? I have to say that as a layman, I have struggled to understand the ruling, but what does the Commission make of this? What is its reaction, and what is it going to do to stop medicinal research in Europe being blocked with the result that it all goes to Asia and the United States, where you can patent such therapeutic inventions – which are, of course, essential, not only for research and innovation and jobs, but also for medicinal treatments?"@en1
lpv:spokenAs	vice-chair; Delegation for relations with the United States (2009-09-16--2014-06-30)3 substitute; Delegation for relations with Albania, Bosnia and Herzegovina, Serbia, Montenegro and Kosovo (2009-09-16--2014-06-30)3 member; LIBE (2009-07-16--2012-01-18)3 unknown; Liberal Democrats Party (2009-07-14--2014-06-30)3 member; ALDE (2009-07-14--2012-07-03)3 substitute; AFET (2009-07-16--2012-01-18)3 substitute; DROI (2009-07-16--2012-01-18)3
lpv:unclassifiedMetadata	"Sarah Ludford (ALDE )."1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph